Australia: DECIPHERA PHARMACEUTICALS Owns Trademark for 'ROMVIMZA' and '4 CHEVRONS'

Australia, June 4 -- DECIPHERA PHARMACEUTICALS LLC, owns the trademark (2514997) for 'ROMVIMZA' and '4 CHEVRONS' till Jan. 20, 2035.

Status: registered: Registered/protected

Classes: 5 [Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors] and 5 [All items in this class are claimed in the convention application.]

Type of Mark: Figurative

Date of Acceptance: Jan. 22

Registration Advertised: June 3

For further details contact AJ Park.

The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2514997.

Disclaimer: Curated by HT Syndication.